SURVIVE: let the dead help the living—an autopsy-based cohort study for mapping risk markers of death among those with severe mental illnesses

[1] Thomsen JL, Banner J: Der dør for mange psykiatriske patienter: Sundhedsstyrelsen bør se nærmere på registreringen af dødsårsager. Ugeskrift for læger 2010, 172(33):2256-2257.Search in Google Scholar

[2] Organization WH: The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines, vol. 1: World Health Organization; 1992.Search in Google Scholar

[3] Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N et al: Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013, 382(9904):1575-1586.10.1016/S0140-6736(13)61611-6Search in Google Scholar

[4] Wahlbeck K, Westman J, Nordentoft M, Gissler M, Laursen TM: Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. The British Journal of Psychiatry 2011, 199(6):453-458.10.1192/bjp.bp.110.085100Search in Google Scholar

[5] Laursen TM, Musliner KL, Benros ME, Vestergaard M, Munk-Olsen T: Mortality and life expectancy in persons with severe unipolar depression. Journal of Affective Disorders, 193:203-207.10.1016/j.jad.2015.12.067Search in Google Scholar

[6] Nordentoft M, Wahlbeck K, Hällgren J, Westman J, Ösby U, Alinaghizadeh H, Gissler M, Laursen TM: Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden. PLOS ONE 2013, 8(1):e55176.10.1371/journal.pone.0055176Search in Google Scholar

[7] Chang CK, Hayes RD, Broadbent M, Fernandes AC, Lee W, Hotopf M, Stewart R: All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 2010, 10:77.10.1186/1471-244X-10-77Search in Google Scholar

[8] Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J: 11-year follow-up of mortality in patients with schizophrenia: a populationbased cohort study (FIN11 study). Lancet 2009, 374(9690):620-627.10.1016/S0140-6736(09)60742-XSearch in Google Scholar

[9] Leucht S, Burkard T, Henderson J, Maj M, Sartorius N: Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007, 116(5):317-333.10.1111/j.1600-0447.2007.01095.x17919153Search in Google Scholar

[10] Brown S, Inskip H, Barraclough B: Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000, 177:212-217.10.1192/bjp.177.3.21211040880Search in Google Scholar

[11] De Hert M, Detraux J, van Winkel R, Yu W, Correll CU: Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 2011, 8(2):114-126.10.1038/nrendo.2011.15622009159Search in Google Scholar

[12] Oud MJ, Meyboom-de Jong B: Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract 2009, 10:32.10.1186/1471-2296-10-32268849619426545Search in Google Scholar

[13] Megna JL, Schwartz TL, Siddiqui UA, Herrera Rojas M: Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions. Ann Clin Psychiatry 2011, 23(2):131-140.Search in Google Scholar

[14] Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, Rosenbaum S, Correll CU: Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 2015, 14(3):339-347.10.1002/wps.20252Search in Google Scholar

[15] Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ: The Metabolic Syndrome and Cardiovascular Risk: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology 2010, 56(14):1113-1132.10.1016/j.jacc.2010.05.034Search in Google Scholar

[16] Weeke P, Jensen A, Folke F, Gislason GH, Olesen JB, Andersson C, Fosbol EL, Larsen JK, Lippert FK, Nielsen SL et al: Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther 2012, 92(1):72-79.10.1038/clpt.2011.368Search in Google Scholar

[17] Ray WA, Chung CP, Murray KT, Hall K, Stein CM: Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death. The New England journal of medicine 2009, 360(3):225-235.10.1056/NEJMoa0806994Search in Google Scholar

[18] Wu CS, Tsai YT, Tsai HJ: Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation-wide Case-Crossover Study. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2015, 4(2):e001568.10.1161/JAHA.114.001568Search in Google Scholar

[19] Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr. et al: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645.10.1161/CIRCULATIONAHA.109.192644Search in Google Scholar

[20] Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. The Lancet 2013, 381(9875):1371-1379.10.1016/S0140-6736(12)62129-1Search in Google Scholar

[21] Newcomer JW: Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005, 19 Suppl 1:1-93.10.2165/00023210-200519001-0000115998156Search in Google Scholar

[22] Beijer U, Andreasson A, Agren G, Fugelstad A: Mortality, mental disorders and addiction: a 5-year follow-up of 82 homeless men in Stockholm. Nord J Psychiatry 2007, 61(5):363-368.10.1080/0803948070164463717990198Search in Google Scholar

[23] Nyhlén A, Fridell M, Bäckström M, Hesse M, Krantz P: Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006. BMC psychiatry 2011, 11(1):122.10.1186/1471-244X-11-122316352121801441Search in Google Scholar

[24] Hjorthøj C, Østergaard MLD, Benros ME, Toftdahl NG, Erlangsen A, Andersen JT, Nordentoft M: Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study. The Lancet Psychiatry 2015, 2(9):801-808.10.1016/S2215-0366(15)00207-2Search in Google Scholar

[25] Basso C, Burke M, Fornes P, Gallagher PJ, de Gouveia RH, Sheppard M, Thiene G, van der Wal A: Guidelines for autopsy investigation of sudden cardiac death. Virchows Archiv 2008, 452(1):11-18.10.1007/s00428-007-0505-517952460Search in Google Scholar

[26] Tidemalm D, Waern M, Stefansson C-G, Elofsson S, Runeson B: Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services. Clinical Practice and Epidemiology in Mental Health : CP & EMH 2008, 4:23-23.Search in Google Scholar

[27] Jones ME, Campbell G, Patel D, Brunner E, Shatapathy CC, Murray-Thomas T, van Staa TP, Motsko S: Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database. Cardiovasc Psychiatry Neurol 2013, 2013:647476.10.1155/2013/647476387659224416588Search in Google Scholar